128 related articles for article (PubMed ID: 31911377)
21. Timing luteal support in assisted reproductive technology: a systematic review.
Connell MT; Szatkowski JM; Terry N; DeCherney AH; Propst AM; Hill MJ
Fertil Steril; 2015 Apr; 103(4):939-946.e3. PubMed ID: 25638420
[TBL] [Abstract][Full Text] [Related]
22. A Phase III randomized controlled trial comparing the efficacy, safety and tolerability of oral dydrogesterone versus micronized vaginal progesterone for luteal support in in vitro fertilization.
Tournaye H; Sukhikh GT; Kahler E; Griesinger G
Hum Reprod; 2017 May; 32(5):1019-1027. PubMed ID: 28333318
[TBL] [Abstract][Full Text] [Related]
23. Effect of Gonadotrophin-Releasing Hormone Agonist Addition for Luteal Support on Pregnancy Outcome in vitro Fertilization/Intracytoplasmic Sperm Injection Cycles: A Meta-Analysis Based on Randomized Controlled Trials.
Ma X; Du W; Hu J; Yang Y; Zhang X
Gynecol Obstet Invest; 2020; 85(1):13-25. PubMed ID: 31422404
[TBL] [Abstract][Full Text] [Related]
24. Luteal phase support with progesterone in intrauterine insemination: a prospective randomized study.
Romero Nieto MI; Lorente González J; Arjona-Berral JE; Del Muñoz-Villanueva M; Castelo-Branco C
Gynecol Endocrinol; 2014 Mar; 30(3):197-201. PubMed ID: 24397361
[TBL] [Abstract][Full Text] [Related]
25. Daily low-dose hCG stimulation during the luteal phase combined with GnRHa triggered IVF cycles without exogenous progesterone: a proof of concept trial.
Andersen CY; Elbaek HO; Alsbjerg B; Laursen RJ; Povlsen BB; Thomsen L; Humaidan P
Hum Reprod; 2015 Oct; 30(10):2387-95. PubMed ID: 26209535
[TBL] [Abstract][Full Text] [Related]
26. Cyclical progestogens for heavy menstrual bleeding.
Bofill Rodriguez M; Lethaby A; Low C; Cameron IT
Cochrane Database Syst Rev; 2019 Aug; 8(8):CD001016. PubMed ID: 31425626
[TBL] [Abstract][Full Text] [Related]
27. Can we alter pregnancy outcome by adjusting progesterone treatment at mid-luteal phase: a randomized controlled trial.
Aslih N; Ellenbogen A; Shavit T; Michaeli M; Yakobi D; Shalom-Paz E
Gynecol Endocrinol; 2017 Aug; 33(8):602-606. PubMed ID: 28277886
[TBL] [Abstract][Full Text] [Related]
28. A comparison of the effects of three luteal phase support protocols with estrogen on in vitro fertilization-embryo transfer outcomes in patients on a GnRH antagonist protocol.
Scheffer JB; Scheffer BB; Carvalho RF; Aguiar AP; Lozano DHM; Labrosse J; Grynberg M
JBRA Assist Reprod; 2019 Aug; 23(3):239-245. PubMed ID: 30875186
[TBL] [Abstract][Full Text] [Related]
29. Meta-analysis of estradiol for luteal phase support in in vitro fertilization/intracytoplasmic sperm injection.
Huang N; Situ B; Chen X; Liu J; Yan P; Kang X; Kong S; Huang M
Fertil Steril; 2015 Feb; 103(2):367-73.e5. PubMed ID: 25492682
[TBL] [Abstract][Full Text] [Related]
30. Estradiol supplementation during the luteal phase of IVF-ICSI patients: a randomized, controlled trial.
Serna J; Cholquevilque JL; Cela V; Martínez-Salazar J; Requena A; Garcia-Velasco JA
Fertil Steril; 2008 Dec; 90(6):2190-5. PubMed ID: 18191847
[TBL] [Abstract][Full Text] [Related]
31. Efficacy and tolerability of vaginal progesterone capsules (Utrogest 200) compared with progesterone gel (Crinone 8%) for luteal phase support during assisted reproduction.
Kleinstein J;
Fertil Steril; 2005 Jun; 83(6):1641-9. PubMed ID: 15950631
[TBL] [Abstract][Full Text] [Related]
32. The effect of endometrial injury on ongoing pregnancy rate in unselected subfertile women undergoing in vitro fertilization: a randomized controlled trial.
Yeung TW; Chai J; Li RH; Lee VC; Ho PC; Ng EH
Hum Reprod; 2014 Nov; 29(11):2474-81. PubMed ID: 25205759
[TBL] [Abstract][Full Text] [Related]
33. Brief co-incubation of sperm and oocytes for in vitro fertilization techniques.
Huang Z; Li J; Wang L; Yan J; Shi Y; Li S
Cochrane Database Syst Rev; 2013 Apr; (4):CD009391. PubMed ID: 23633370
[TBL] [Abstract][Full Text] [Related]
34. In vitro fertilisation for unexplained subfertility.
Pandian Z; Bhattacharya S; Vale L; Templeton A
Cochrane Database Syst Rev; 2005 Apr; (2):CD003357. PubMed ID: 15846658
[TBL] [Abstract][Full Text] [Related]
35. Dydrogesterone: pharmacological profile and mechanism of action as luteal phase support in assisted reproduction.
Griesinger G; Tournaye H; Macklon N; Petraglia F; Arck P; Blockeel C; van Amsterdam P; Pexman-Fieth C; Fauser BC
Reprod Biomed Online; 2019 Feb; 38(2):249-259. PubMed ID: 30595525
[TBL] [Abstract][Full Text] [Related]
36. Early progesterone cessation after in vitro fertilization/intracytoplasmic sperm injection: a randomized, controlled trial.
Kohls G; Ruiz F; Martínez M; Hauzman E; de la Fuente G; Pellicer A; Garcia-Velasco JA
Fertil Steril; 2012 Oct; 98(4):858-62. PubMed ID: 22749223
[TBL] [Abstract][Full Text] [Related]
37. Impact of luteal phase support with vaginal progesterone on the clinical pregnancy rate in intrauterine insemination cycles stimulated with gonadotropins: a randomized multicenter study.
Peeraer K; D'Hooghe T; Laurent P; Pelckmans S; Delvigne A; Laenen A; Welkenhuysen M; Wyns C; De Neubourg D
Fertil Steril; 2016 Nov; 106(6):1490-1495. PubMed ID: 27565253
[TBL] [Abstract][Full Text] [Related]
38. The role of luteal support during IVF: a qualitative systematic review.
Tomic V; Kasum M; Vucic K
Gynecol Endocrinol; 2019 Oct; 35(10):829-834. PubMed ID: 31032676
[TBL] [Abstract][Full Text] [Related]
39. Dydrogesterone vs progesterone for luteal-phase support: systematic review and meta-analysis of randomized controlled trials.
Barbosa MW; Silva LR; Navarro PA; Ferriani RA; Nastri CO; Martins WP
Ultrasound Obstet Gynecol; 2016 Aug; 48(2):161-70. PubMed ID: 26577241
[TBL] [Abstract][Full Text] [Related]
40. Effect of local endometrial injury in proliferative vs. luteal phase on IVF outcomes in unselected subfertile women undergoing in vitro fertilization.
Liu W; Tal R; Chao H; Liu M; Liu Y
Reprod Biol Endocrinol; 2017 Sep; 15(1):75. PubMed ID: 28938896
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
